Use of SSRIs With Oral Anticoagulants and Risk of Major Bleeding
April 12, 2024
A recent population-based, nested case-control study assessed wheth...
Read More
Metabolic Markers Tied to Increased Risk of Mental Disorders
April 6, 2024
A recent study examined whether the biomarkers of carbohydrate, lip...
Read More
FDA Approves Treatment for Mixed, Manic Episodes Associated With Bipolar I Disorder
April 3, 2024
The FDA has expanded the approval iloperidone to include for the ac...
Read More
Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia
April 2, 2024
In a recent study examined the efficacy of various treatments for a...
Read More
FDA Clears First Prescription Digital Therapeutic Authorized for Treatment of MDD
April 1, 2024
The FDA has cleared the first prescription digital therapeutic auth...
Read More
World Bipolar Day Is Celebrated Each Year On March 30th
March 30, 2024
World Bipolar Day is celebrated each year on March 30th. World Bipo...
Read More
Stimulants and Sleep Difficulties in Pediatric ADHD
March 28, 2024
A recent comprehensive study delved into the long-term effects of m...
Read More
Pharmacological Treatments for Psychotic Depression
March 22, 2024
Current treatment guidelines for psychotic depression recommend a c...
Read More
CDC Issues New Guidance on Identifying, Responding to Suicide Clusters
March 19, 2024
Responding to suicide clusters requires a comprehensive and proacti...
Read More
ADHD Pharmacotherapy and Mortality in Individuals With ADHD
March 18, 2024
A recent study explored whether initiation of ADHD pharmacotherapy ...
Read More
Caffeine Consumption and Anxiety
March 16, 2024
Anxiety disorders affect approximately 264 million individuals worl...
Read More
LSD-Based Treatment for GAD Receives Breakthrough Therapy Designation from the FDA
March 13, 2024
A recent study shows that their lysergic acid diethylamide (LSD)-ba...
Read More